More Than Half of Patients with CU Are Very to Extremely Interested in an App to Monitor Disease Activity and Control
Over half of patients were very or extremely interested in the development of an app to monitor disease activity (51%; n=946) and control (53%; n=967), while only ~1/10 were not interested at all in apps to assess such parameters (urticaria activity, 12.8%, n=236; urticaria control, 12.0%, n=221).